alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.2****CERTIFICATION**     I, David A. Husband, certify that:     1. I have reviewed this quarterly report on Form 10-Q of Vodavi Technology, Inc.;     2. Based on my knowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, in light of thecircumstances under which such statements were made, not misleading with respect to the periodcovered by this report;     3. Based on my knowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financial condition, results ofoperations, and cash flows of the registrant as of, and for, the periods presented in this report;     4. The registrant’s other certifying officer(s) and I are responsible for establishing andmaintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:     a) Designed such disclosure controls and procedures, or caused such disclosure controlsand procedures to be designed under our supervision, to ensure that material informationrelating to the registrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which this report is beingprepared;     b) Evaluated the effectiveness of the registrant’s disclosure controls and proceduresand presented in this report our conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered by this report based on suchevaluation; and     c) Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that has materiallyaffected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and;     5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’s auditors and the auditcommittee of the registrant’s board of directors (or persons performing the equivalent functions):     a) All significant deficiencies and material weaknesses in the design or operation ofinternal control which are reasonably likely to adversely affect the registrant’s ability torecord, process, summarize, and report financial information ; and     b) Any fraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financial reporting.Date: August 1, 2005                                                       /s/ David A. Husband   David A. Husband   Chief Financial Officer  
19
#### Clyde BEL, Sr., d/b/a Bel for Awnings v. CAPITAL PROPERTIES, INC., d/b/a Delta Towers Hotel.

No. 62436.

Supreme Court of Louisiana.

June 30, 1978.

In re: Clyde Bel, Sr., d/b/a Bel for Awnings, applying for certiorari, or writ of review, to the 4th Circuit Court of Appeal. Parish of Orleans. 357 So.2d 1330.

Writ denied.

CALOGERO, J., would grant the writ.
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF BLUE WAVE SYSTEMS INC. AS OF SEPTEMBER 30, 1998 AND FOR
THE THREE MONTHS THEN ENDED AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1999
<PERIOD-START>                             JUL-01-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                           3,580
<SECURITIES>                                     1,093
<RECEIVABLES>                                    5,986
<ALLOWANCES>                                       229
<INVENTORY>                                      3,704
<CURRENT-ASSETS>                                15,659
<PP&E>                                          10,337
<DEPRECIATION>                                   6,183
<TOTAL-ASSETS>                                  20,400
<CURRENT-LIABILITIES>                            9,887
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           135
<OTHER-SE>                                       8,636
<TOTAL-LIABILITY-AND-EQUITY>                    20,400
<SALES>                                          6,806
<TOTAL-REVENUES>                                 6,806
<CGS>                                            3,227
<TOTAL-COSTS>                                    3,227
<OTHER-EXPENSES>                                 4,339
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  60
<INCOME-PRETAX>                                   (754)
<INCOME-TAX>                                        23
<INCOME-CONTINUING>                               (777)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (777)
<EPS-PRIMARY>                                     (.06)
<EPS-DILUTED>                                     (.06)
        

</TABLE>
# A

http://www.census.gov/housing/hvs/data/ann17def.html
#### LEEWARD CORPORATION v. ISAACSON.

No. 39318.

Supreme Court of Florida.

Feb. 1970.

Certiorari denied without opinion. 229 So.2d 19.
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-11-00802-CV

Robert David NALBACH,

Appellant

v.

Stephanie Dawn NALBACH,

Appellee

From the 166th Judicial District Court, Bexar County, Texas

Trial Court No. 2010-CI-14091

Honorable Martha Tanner, Judge Presiding

BEFORE JUSTICE ANGELINI, JUSTICE ALVAREZ, AND JUSTICE CHAPA

In accordance with this court’s opinion of this date, the trial court’s judgment is affirmed. 

It is ORDERED that appellee Stephanie Dawn Nalbach recover her costs of this appeal 

from appellant Robert David Nalbach. 

SIGNED April 17, 2013.

_____________________________

Luz Elena D. Chapa, Justice
July 30, 2015

Mr. Kyle Ferreira

286 Werimus Road

Woodcliff Lake, NJ 07677

Dear Mr. Ferreira:

This letter is to inform you that we are unable to process your request for an exemption from 

Title 14, Code of Federal Regulations (14 CFR). It explains why we can not process your 

request and what you should do in the next 30 days.

Why We Can Not Process Your Request

We entered your May 13, exemption request into the public docket (No. FAA-2015-1634), but 

we are unable to process your request any further. The information you sent does not comply

with the requirements of § 11.81 (copy enclosed). For us to consider the request any further, 

you must send us all of the following:

 The reasons why granting the request would be in the public interest; that is, how it would 

benefit the public as a whole.

 Any additional information, views, or arguments available to support your request.

What You Should Do

If you want us to process your request any further, you must send the information described 

earlier to reach us within 30 days. Please note that § 11.63(d) requires you to send your 

petition for exemption at least 120 days before the proposed effective date of the exemption.
2

If We Do Not Hear From You

If we do not hear from you within 30 days, we will close the docket without notifying you 

further. If you have any questions or require additional time, you may call (202) 267-9677.

Sincerely,

/s/

Brittany Newton

Program Analyst, Airmen and 

 Airspace Rules Division

Enclosure
#### Charles Wayne JEFFERS, Appellant, v. STATE of Florida, Appellee.

No. 71-313.

District Court of Appeal of Florida, Fourth District.

June 3, 1971.

Appeal from Circuit Court, Osceola County; Claude R. Edwards, Judge.

Appeal dismissed.
```

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 2037 Introduced in Senate (IS)]

113th CONGRESS
  2d Session
                                S. 2037

 To amend title XVIII of the Social Security Act to remove the 96-hour 
   physician certification requirement for inpatient critical access 
                           hospital services.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 24, 2014

Mr. Roberts (for himself, Mr. Tester, Mr. Inhofe, Mr. Durbin, Mr. Enzi, 
 Ms. Baldwin, Mr. Moran, Mr. Franken, Mr. Grassley, Mr. Barrasso, Mrs. 
 Fischer, Ms. Collins, Mr. Johanns, Ms. Klobuchar, Mr. Hoeven, and Mr. 
Kirk) introduced the following bill; which was read twice and referred 
                      to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
 To amend title XVIII of the Social Security Act to remove the 96-hour 
   physician certification requirement for inpatient critical access 
                           hospital services.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Critical Access Hospital Relief Act 
of 2014''.

SEC. 2. REMOVING MEDICARE 96-HOUR PHYSICIAN CERTIFICATION REQUIREMENT 
              FOR INPATIENT CRITICAL ACCESS HOSPITAL SERVICES.

    (a) In General.--Section 1814(a) of the Social Security Act (42 
U.S.C. 1395f(a)) is amended--
            (1) in paragraph (6), by adding ``and'' at the end;
            (2) in paragraph (7), at the end of subparagraph (D)(ii), 
        by striking ``and'' and inserting a period; and
            (3) by striking paragraph (8).
    (b) Application.--The amendments made by subsection (a) shall apply 
with respect to items and services furnished on or after January 1, 
2014.
                                 <all>
```
#### STATE of Louisiana ex rel. Sephious F. HARRIS v. C. Murray HENDERSON, Warden, Louisiana State Penitentiary.

No. 53058.

Supreme Court of Louisiana.

Jan. 25, 1973.

In re: Sephious F. Harris applying for remedial writs and writ of habeas corpus.

Writ denied. The transcript fully supports the trial judge’s findings that relator is not entitled to the relief sought.
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 292 Introduced in House (IH)]

103d CONGRESS
  1st Session
                                H. R. 292

To provide for the establishment of a new medical facility for veterans 
                            in south Texas.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 5, 1993

 Mr. Ortiz (for himself and Mr. de la Garza) introduced the following 
     bill; which was referred to the Committee on Veterans' Affairs

_______________________________________________________________________

                                 A BILL

 
To provide for the establishment of a new medical facility for veterans 
                            in south Texas.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. NEW VETERANS' ADMINISTRATION MEDICAL FACILITY IN SOUTH 
              TEXAS.

    (a) Project Authorization.--The Secretary of Veterans Affairs is 
authorized--
            (1) to acquire a site in south Texas suitable for a medical 
        facility; and
            (2) to construct a medical facility on such site.
    (b) Funding.--There are authorized to be appropriated such sums as 
may be necessary for the purposes of subsection (a), but the amount 
appropriated for the construction of the medical facility may not 
exceed the product of (1) the number of beds to be included in the 
facility, and (2) $290,000.
    (c) Definition.--For purposes of this section, the term ``medical 
facility'' has the meaning given the term in section 5001(3) of title 
38, United States Code.

                                 <all>
```
Exhibit 10.1

 

TRIUMPH GROUP, INC.

 

NOMINATING AND CORPORATE GOVERNANCE COMMITTEE MEETING

 

Non-employee Director Compensation Program

 

Effective July 21, 2016

 

	
Annual
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
Retainer for
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
each
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    
	
Non-employee
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Additional
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Annual
    	
 
    
	
Board
    	
 
    	
Additional Retainer for
    	
 
    	
Retainer for
    	
 
    	
 
    	
 
    	
Telephonic
    	
 
    	
Equity Award
    	
 
    
	
Member (1)
    	
 
    	
Committee Chairs
    	
 
    	
Lead Director
    	
 
    	
Meeting Fees
    	
 
    	
Meeting Fees
    	
 
    	
(1)
    	
 
    
	
$
    	
85,000
    	
 
    	
Audit
    	
 
    	
$
    	
15,000
    	
 
    	
$
    	
100,000
    	
 
    	
N/A
    	
 
    	
N/A
    	
 
    	
Restricted
    	
 
    
	
 
    	
 
    	
Comp.
    	
 
    	
$
    	
10,000
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
Stock Units
    	
 
    
	
 
    	
 
    	
N&CG
    	
 
    	
$
    	
7,500
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
with a grant
    	
 
    
	
 
    	
 
    	
Finance
    	
 
    	
$
    	
5,000
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
date value of
    	
 
    
	
 
    	
 
    	
Other
    	
 
    	
$
    	
5,000
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
approximately
    	
 
    
	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
 
    	
$ 140,000
    	
 
    
																	


 




(1)                                 Each non-employee director can defer all or a portion of his or her annual retainer fees and/or  annual equity award pursuant to the Directors’ Deferred Compensation Plan.

 

Ratified and affirmed:  November 10, 2016
# C_2014036EN.01000102.xml

| 7.2.2014 | EN | Official Journal of the European Union | C 36/1 |
| --- | --- | --- | --- |

7.2.2014

EN

Official Journal of the European Union

C 36/1

---

Non-opposition to a notified concentration

(Case COMP/M.7063 — Vestas Wind Systems/Mitsubishi Heavy Industries/JV)

(Text with EEA relevance)

2014/C 36/02

On 30 January 2014, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32014M7063. EUR-Lex is the online access to the European law. |
| --- | --- |

—

in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/en/index.htm) under document number 32014M7063. EUR-Lex is the online access to the European law.

---
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule containing summary financial information extracted from the
condensed consolidated balance sheet at February 29, 2000 (unaudited) and the
consolidated statement of operations for the nine months ended February 29, 2000
(unaudited) is qualified in its entirety by reference to such financial
statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAY-31-2000
<PERIOD-START>                             JUN-01-1999
<PERIOD-END>                               FEB-29-2000
<CASH>                                          12,525
<SECURITIES>                                    98,188
<RECEIVABLES>                                   17,840
<ALLOWANCES>                                       900
<INVENTORY>                                          0
<CURRENT-ASSETS>                               132,140
<PP&E>                                          19,678
<DEPRECIATION>                                  14,638
<TOTAL-ASSETS>                                 168,554
<CURRENT-LIABILITIES>                           27,485
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            31
<OTHER-SE>                                     141,038
<TOTAL-LIABILITY-AND-EQUITY>                   168,554
<SALES>                                         47,081
<TOTAL-REVENUES>                                65,702
<CGS>                                              571
<TOTAL-COSTS>                                    6,531
<OTHER-EXPENSES>                                43,810
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  20
<INCOME-PRETAX>                                 19,280
<INCOME-TAX>                                       450
<INCOME-CONTINUING>                             18,830
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    18,830
<EPS-BASIC>                                       0.64
<EPS-DILUTED>                                     0.55


</TABLE>
# C_2013366EN.01000401.xml

| 14.12.2013 | EN | Official Journal of the European Union | C 366/4 |
| --- | --- | --- | --- |

14.12.2013

EN

Official Journal of the European Union

C 366/4

---

Euro exchange rates (1)

1

13 December 2013

(2013/C 366/03)

1 euro =

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,3727 |
| JPY | Japanese yen | 141,93 |
| DKK | Danish krone | 7,4611 |
| GBP | Pound sterling | 0,84370 |
| SEK | Swedish krona | 9,0351 |
| CHF | Swiss franc | 1,2226 |
| ISK | Iceland króna | |
| NOK | Norwegian krone | 8,4900 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 27,534 |
| HUF | Hungarian forint | 302,42 |
| LTL | Lithuanian litas | 3,4528 |
| LVL | Latvian lats | 0,7030 |
| PLN | Polish zloty | 4,1796 |
| RON | Romanian leu | 4,4573 |
| TRY | Turkish lira | 2,7992 |
| AUD | Australian dollar | 1,5355 |
| CAD | Canadian dollar | 1,4626 |
| HKD | Hong Kong dollar | 10,6430 |
| NZD | New Zealand dollar | 1,6691 |
| SGD | Singapore dollar | 1,7251 |
| KRW | South Korean won | 1 446,78 |
| ZAR | South African rand | 14,1407 |
| CNY | Chinese yuan renminbi | 8,3367 |
| HRK | Croatian kuna | 7,6283 |
| IDR | Indonesian rupiah | 16 496,17 |
| MYR | Malaysian ringgit | 4,4425 |
| PHP | Philippine peso | 60,620 |
| RUB | Russian rouble | 45,0965 |
| THB | Thai baht | 44,002 |
| BRL | Brazilian real | 3,2005 |
| MXN | Mexican peso | 17,7782 |
| INR | Indian rupee | 85,3350 |

Currency

Exchange rate

USD

US dollar

1,3727

JPY

Japanese yen

141,93

DKK

Danish krone

7,4611

GBP

Pound sterling

0,84370

SEK

Swedish krona

9,0351

CHF

Swiss franc

1,2226

ISK

Iceland króna

NOK

Norwegian krone

8,4900

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

27,534

HUF

Hungarian forint

302,42

LTL

Lithuanian litas

3,4528

LVL

Latvian lats

0,7030

PLN

Polish zloty

4,1796

RON

Romanian leu

4,4573

TRY

Turkish lira

2,7992

AUD

Australian dollar

1,5355

CAD

Canadian dollar

1,4626

HKD

Hong Kong dollar

10,6430

NZD

New Zealand dollar

1,6691

SGD

Singapore dollar

1,7251

KRW

South Korean won

1 446,78

ZAR

South African rand

14,1407

CNY

Chinese yuan renminbi

8,3367

HRK

Croatian kuna

7,6283

IDR

Indonesian rupiah

16 496,17

MYR

Malaysian ringgit

4,4425

PHP

Philippine peso

60,620

RUB

Russian rouble

45,0965

THB

Thai baht

44,002

BRL

Brazilian real

3,2005

MXN

Mexican peso

17,7782

INR

Indian rupee

85,3350

---

(1)  Source: reference exchange rate published by the ECB.

1

Source

---
<PAGE>


                                                                   EXHIBIT 21.1


                                  SUBSIDIARIES
                                       OF
                                 DATASCOPE CORP.

         The following table lists, as of June 30, 2002, the direct and indirect
subsidiaries of Datascope Corp., the jurisdiction of organization and the
percentage of voting securities owned by the immediate parent of each
subsidiary:

                                                        Where           % of
                                                        Incorporated    Voting
                                                        ------------    -------
      Stock

      Datascope FSC, Ltd.                               Barbados          100

      Datascope Investment Corp.                        New Jersey        100

      Datascope B.V.                                    Netherlands       100
               Datascope Medical Co. Ltd.               United Kingdom    100
               Datascope S.A.R.L.                       France            100
               Datascope GmbH                           Germany           100
               InterVascular S.A.S.                     France            100
               Datascope S.L.                           Spain             100
               Datascope Interventional GmbH            Germany           100

      Bioplex Corp.                                     Delaware          100
               Bioplex Medical B.V.                     Netherlands       100

      Datascope Biomaterials Research B.V.              Netherlands       100

      Genisphere, Inc.                                  Delaware           83

      InterVascular Inc.                                Delaware          100
               InterVascular S.A.R.L.                   France            100
               InterVascular GmbH                       Germany           100
               Datascope Italia S.R.L.                  Italy             100
               Datascope S.P.R.L.                       Belgium           100
               Datascope Trademark Corp.                Delaware          100